| Annual Financials | 2020 | 2021 | TTM |
Revenue  | 544 | 508 | 0 |
| Expenses | 325 | 293 | 0 |
| EBITDA | 220 | 215 | 0 |
| Operating Profit % | 40 % | 41 % | 0 % |
| Depreciation | 18 | 20 | 0 |
| Interest | 7 | 5 | 0 |
| Profit Before Tax | 194 | 185 | 0 |
| Tax | 49 | 49 | 0 |
| Net Profit | 145 | 136 | 0 |
| EPS in ₹ | 1,462.60 | 1,396.27 | 0.00 |
Blue Jet Healthcare
878.30
+37.40
(4.45%)
Market Cap
14,586.70 Cr
EPS
1,396.27
PE Ratio
49.87
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
968.30
52 Week Low
347.60
PB Ratio
13.43
Debt to Equity
0.24
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from6 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,666.40 | #1 4,03,904.00 | 34.84 | #1 49,887.20 | 12.06 | #1 9,648 | -18.99 | 38.78 | |
6,636.00 | 1,77,810.90 | 80.39 | 8,184.00 | 0.89 | 1,600 | 23.05 | 64.74 | |
1,468.50 | 1,19,567.40 | 22.50 | 26,520.70 | 14.17 | 4,155 | 30.28 | 44.52 | |
3,165.90 | 1,07,480.10 | 55.51 | 10,785.70 | 11.59 | 1,656 | 10.91 | 43.23 | |
1,242.60 | 1,03,739.50 | #1 18.35 | 28,905.40 | 12.36 | 5,578 | 21.14 | 65.27 | |
2,483.80 | 1,01,279.80 | 51.58 | 10,615.60 | 19.57 | 1,942 | -10.91 | 50.67 | |
925.60 | 92,382.30 | 19.93 | 19,831.50 | 13.82 | 3,831 | -0.19 | 61.91 | |
1,941.60 | 89,947.70 | 27.02 | 20,141.50 | #1 19.94 | 1,936 | #1 112.49 | 40.27 | |
1,147.80 | 69,185.10 | 19.30 | 29,559.20 | 17.55 | 3,169 | -0.50 | 41.95 | |
30,120.00 | 64,629.80 | 45.31 | 6,097.20 | 10.80 | 1,201 | 27.83 | 46.13 |
Forecast
Actual
Growth Rate
Revenue Growth
-6.62 %
Net Income Growth
-6.34 %
Cash Flow Change
5.34 %
ROE
-44.11 %
ROCE
-38.82 %
EBITDA Margin (Avg.)
4.85 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 |
| Total Assets | 375 | 536 |
| Fixed Assets | 107 | 139 |
| Current Assets | 249 | 390 |
| Capital Work in Progress | 2 | 3 |
| Investments | 34 | 37 |
| Other Assets | 233 | 358 |
| Total Liabilities | 375 | 536 |
| Current Liabilities | 133 | 163 |
| Non Current Liabilities | 39 | 33 |
| Total Equity | 203 | 340 |
| Reserve & Surplus | 182 | 320 |
| Share Capital | 1 | 10 |
Cash Flow
| Cash Flow | 2020 | 2021 |
| Net Cash Flow | 5 | 51 |
| Investing Activities | -45 | -51 |
| Operating Activities | 123 | 129 |
| Financing Activities | -73 | -28 |
Share Holding
| % Holding | Sept 2022 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 100.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 2.01 % | 2.02 % | 2.18 % | 1.10 % | 2.29 % |
| DIIs | 0.00 % | 3.32 % | 2.81 % | 3.03 % | 2.14 % | 1.74 % | 2.02 % | 1.33 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 6.97 % | 4.73 % | 5.36 % | 5.79 % | 5.90 % | 6.30 % | 7.28 % |
| Others | 0.00 % | 3.71 % | 6.46 % | 3.60 % | 4.04 % | 4.17 % | 4.57 % | 3.10 % |
| No of Share Holders | 7 | 2,03,777 | 55,589 | 48,625 | 42,882 | 41,933 | 43,003 | 54,581 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 May 2025 |  Quarterly Result Announcement | NA | 14 May 2025 | 723.30 | 769.30 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 581.00 | 572.95 |
| 29 Oct 2024 | Quarterly Result Announcement | NA | 29 Oct 2024 | 473.65 | 480.30 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 517.20 | 537.80 |
| 18 Sept 2024 |  Dividend | ₹ 1.00 /share | 17 Sept 2024 | 375.60 | 526.85 |
Announcements
Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
6 days ago
6 days agoDisclosure under Regulation 30A of LODR6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Notice Of Postal BallotMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 14, 2025
May 14, 2025Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationMay 14, 2025
May 14, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
May 14, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 14, 2025
May 14, 2025Outcome Of Board MeetingMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 To Be Held On May 14 2025May 09, 2025
May 09, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2025
Apr 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Apr 03, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 01, 2025
Apr 01, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Mar 18, 2025Intimation Of Investor/Analyst - Plant VisitMar 07, 2025
Mar 07, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 17, 2025
Feb 17, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Feb 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2025
Jan 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJan 29, 2025
Jan 29, 2025Integrated Filing (Financial)Jan 29, 2025
Jan 29, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 29Th January 2025Jan 29, 2025
Jan 29, 2025Unaudited Financial Results For The Quarter Ended 31St December 2024Jan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2025
Jan 27, 2025Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015Jan 22, 2025
Jan 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 16, 2025
Jan 16, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 15, 2025
Jan 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Jan 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 11, 2024
Dec 11, 2024Disclosure Under Regulation 30, Schedule III Of SEBI LODR Regulations 2015- Commissioning Of Production Block At Ambernath Unit IIDec 10, 2024
Dec 10, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateNov 19, 2024
Nov 19, 2024Regulation 30 Of SEBI (LODR), 2015 Intimation Of Consent To Operate At Company''s Mahad Unit, Maharashtra From Maharashtra Pollution Control BoardNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 08, 2024
Nov 08, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2024
Nov 04, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 04, 2024
Nov 04, 2024Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2024
Oct 30, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2024
Oct 30, 2024Results Of Financials For Half Year And Quarter Ended September 30, 2024Oct 29, 2024
Oct 29, 2024Technical Indicators
RSI(14)
Neutral 67.20
ATR(14)
Volatile 42.19
STOCH(9,6)
Neutral 67.07
STOCH RSI(14)
Overbought 86.75
MACD(12,26)
Bullish 10.36
ADX(14)
Weak Trend 17.71
UO(9)
Bearish 54.19
ROC(12)
Uptrend And Accelerating 19.55
WillR(14)
Overbought -5.22
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 TRUSTMF Flexi Cap Fund Direct - Growth | 0 | 0.00% | -1.02% | -0.70% | Apr 2025 | |
 Samco Active Momentum Fund Direct - Growth | 0 | 0.00% | -0.94% | -0.84% | Apr 2025 | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 0 | 0.00% | -0.76% | -0.68% | Apr 2025 | |
| TRUSTMF Small Cap Fund Direct-Growth | 203789 | 1.70% | -0.65% | -0.52% | Apr 2025 | |
| Samco Special Opportunities Fund Direct - Growth | 43601 | 2.07% | -0.54% | 2.07% | Apr 2025 | |
 UTI Small Cap Fund Direct - Growth | 506107 | 0.85% | -0.23% | -0.34% | Apr 2025 | |
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 71618 | 0.26% | -0.07% | -0.05% | Apr 2025 | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 346 | 0.14% | -0.03% | -0.02% | Apr 2025 | |
 HDFC Business Cycle Fund Direct - Growth | 0 | 0.00% | -0.03% | -0.20% | Apr 2025 | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth | 0 | 0.00% | 0.00% | -0.42% | Apr 2025 | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 50 | 0.01% | 0.00% | 0.00% | Apr 2025 | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 43 | 0.01% | 0.00% | 0.01% | Apr 2025 | |
| Samco Multi Cap Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
 Groww Nifty Total Market Index Fund Direct - Growth | 364 | 0.01% | 0.00% | 0.00% | Apr 2025 | |
 Edelweiss Recently Listed IPO Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Edelweiss Aggressive Hybrid Fund Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Bandhan Small Cap Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | Apr 2025 | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 49 | 0.01% | 0.00% | 0.00% | Apr 2025 |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
